Drug Abuse Testing Market to Reach US$ 9,393.17 Mn at a CAGR of 5.7% in 2027 | The Insight Partners

Drug Abuse Testing Market to 2027 - Global Analysis and Forecasts by Product (Rapid Testing Devices, Analyzers and Consumables); Sample Type (Blood, Urine, Saliva and Other Sample Types); End User (Hospitals, Diagnostic Laboratories and Forensic Laboratories) and Geography

Publication Month: Aug 2019 | Report Code: TIPHE100001303 | No. of Pages: 155 | Category: Medical Device | Status: Published

The global drug abuse testing market expected to be US$ 5,783.71 Mn in 2018 and is predicted to grow at a CAGR of 5.7% during the forecast period 2019 - 2027, to reach US$ 9,393.17 Mn by 2027.

Europe is the second largest geographic market is expected to witness significant growth during the forecast period, due to rise in the use of illicit substances and incidences of death due to drug overdose. In addition, the presence of government policies are expected to offer growth opportunities in the market during the forecast period.

 

Exhibit: Lucrative Regional Drug Abuse Testing Markets

 

Market Insights

Increasing Consumption of Illicit Drugs

Illicit drugs, including cocaine, amphetamines, heroin, hallucinogens are substances that can inhibit the central nervous system and also cause hallucinogenic effects. The National Household Survey on Drug Abuse (NSDUH) is a primary source of information on the patterns, prevalence, and consequences of alcohol, illegal drug use, and abuse in the general U.S.

 

 As per statistics provided by the National Survey on Drug Use and Health (NSDUH), approximately 19.7 million American adults (above 12 years of age) have faced a substance use disorder in 2017. According to SAMHSAM, marijuana is the most commonly used illicit drug in the United States. The laws regarding the use of marijuana have changed in several countries over the past decades. Marijuana classified as a Schedule I drug that is considered as having a high potential for drug abuse that has no currently accepted medical use in treatment in the United States yet. Almost 38% of the adult population in the U.S. have battled an illegal drug use disorder during the year 2017. Other than illicit drugs, the consumption of alcohol has observed among the individuals in the country. Nearly 74% of adults suffering from a substance use disorder in 2017 also struggled with an alcohol use disorder.

 

Across the United States, the increasing consumption of marijuana has a public health impact on local and state communities. As in results, people meeting the diagnostic standards for abuse or dependence on marijuana, which is the second leading factor for which people receive drug treatment (behind alcohol). As per the White House Office of National Drug Control Policy, the consequences of marijuana use have placed a substantial strain on the U.S. health care system. Therefore, owing to the factors mentioned above, the market for drug abuse testing is anticipated to grow significantly in the forecast period.

 

Laws and Regulations Related to Drug Abuse

Drug use in excess can have a wide range of short and long-term, direct, and indirect effects. Short-term effects can range from changes in restlessness, appetite, blood pressure, heart rate, stroke or heart attack, psychosis, overdose, and even death. These health-related effects can occur even after just one use of drugs. On the other hand, longer-term effects can include cancer, heart or lung disease, mental illness, hepatitis, HIV/AIDS, and others. The long-term drug use can also lead to an addiction that results in brain disorders such as, anxiety, paranoia, depression, aggression, hallucinations, and others. For instance, according to the National Institute of Drug use, approx. 43.4 million (17.9%) adults ages 18 and older experienced some form of mental illness in 2015, in which 8.1 million had both a substance use disorder and another mental illness.

 

The increasing use of illicit drugs is subjected to various regulations. The government conducts many acts for the law or regulation on drug abuse including SUPPORT Act, 21st Century Cures Act, Comprehensive Addiction and Recovery Act (CARA), Affordable Care Act (ACA), Tribal Law and Order Act (TLOA), Mental Health Parity and Addiction Equity Act, Americans with Disabilities Act (ADA), Sober Truth on Preventing (STOP) Underage Drinking Act, Garrett Lee Smith Memorial Act and Children’s Health Act.

 

According to the federal laws related to SAMHSA, SUPPORT Act promotes opioid recovery and treatment for Patients and Communities Act of 2018, was made a law to address the overdose of wide-ranging illicit drugs. Moreover, the 21st Century Cures Act was signed into law on December 2016. The act addresses many critical issues at the federal level, including accountability and leadership for mental or behavioral health disorders. The Cures Act also organized the Center for Behavioral Health Statistics and Quality (CBHSQ) that serves as the federal government’s lead agency for behavioral health statistics.

 

Moreover, the Comprehensive Addiction and Recovery Act (CARA) is imposed in 2016, that launched an evidence-based heroin and illicit drugs treatment and interventions program that further enforce prescription drug monitoring programs to help states monitor and track prescription drug alteration. The act also helps to expand prevention and educational efforts that mainly aimed at teens, parents, and aging populations. Hence, the increase in mental disorder cases due to use of the high doses of drugs is anticipated to help the market for drug-abuse testing in the forecast period.

 

Product Insights

The global drug abuse testing market by product was led by consumables segment. In 2018, the segment of held the largest market share in the drug abuse testing market, by product. The segment is also expected to witness growth at a significant rate during the forecast period as it form an essential part of drug abuse testing, its demand is expected to grow at a considerable pace during the future years.

 

Exhibit: Drug Abuse Testing Market, by Product

 

 

DRUG ABUSE TESTING – MARKET SEGMENTATION

 

By Product

  • Rapid Testing Devices
  • Analyzers
  • Consumables

 

By Sample Type

  • Urine
  • Saliva
  • Blood
  • Others

 

By End User

  • Hospitals
  • Diagnostic Laboratories
  • Forensic Laboratories

 

By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • UK
    • Spain
    • Italy
  • Asia Pacific (APAC)
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • Middle East & Africa (MEA)
    • Saudi Arabia
    • South Africa
    • UAE
  • South and Central America
    • Brazil
    • Argentina

Company Profiles

  • Redwood Toxicology Laboratory (Abbott)
  • F. Hoffmann-La Roche Ltd.
  • Thermo Fisher Scientific, Inc.
  • OraSure Technologies, Inc.
  • UCP Biosciences
  • MEDACX Ltd.
  • Beckman Coulter, Inc. (Danaher)
  • Alcolizer Pty Ltd.
  • Wondfo
  • DRÄGERWERK AG & CO. KGAA
  • American Screening Corporation, Inc
  • Mercedes Medical, Alfa Scientific Designs, Inc.
  • Express Diagnostics Int'l, Inc.
  • Omega Laboratories, Inc.
  • Laboratorio Sodré.

1.             Introduction

1.1       Scope of the Study

1.2       The Insight Partners Research Report Guidance

1.3       Market Segmentation

1.3.1        Global Drug Abuse Testing Market – By Product

1.3.2        Global Drug Abuse Testing Market – By Sample Type

1.3.3        Global Drug Abuse Testing Market – By End User

1.3.4        Global Drug Abuse Testing Market – By Geography

2.             Global Drug Abuse Testing Market – Key Takeaways

3.             Research Methodology

3.1       Coverage

3.2       Secondary Research

3.3       Primary Research

4.             Global Drug Abuse Testing Market Landscape

4.1       Overview

4.2       Pest Analysis

4.2.1        North America PEST Analysis

4.2.2        Europe PEST Analysis

4.2.3        Asia Pacific PEST Analysis

4.2.4        Middle East & Africa PEST Analysis

4.2.5        South & Central America PEST Analysis

4.3       Expert Opinion

5.             Global Drug Abuse Testing Market – Key Industry Dynamics

5.1       Key Market Drivers

5.1.1        Increasing Consumption of Illicit Drugs

5.1.2        Laws and Regulations Related to Drug Abuse

5.2       Key Market Restraints

5.2.1        Dearth of Trained Laboratory Professionals

5.3       Key Market Opportunities

5.3.1        Growing Adoption of LIMS in Cannabis Testing Laboratories

5.3.2        Advances in Drug Testing Consumables:

5.4       Impact Analysis

6.             Drug Abuse Testing Market – Global Analysis

6.1       Global Drug Abuse Testing Market Revenue Forecasts And Analysis

6.2       Global Drug Abuse Testing Market, By Geography - Forecasts And Analysis

6.3       Positioning Of Key Players

7.             Global Drug Abuse Testing Market Analysis– by Product

7.1       Overview

7.2       Global Drug Abuse Testing Market Share by Product 2018 & 2027 (%)

7.3       Rapid Testing Devices

7.3.1        Overview

7.3.2        Rapid Testing Devices Market Revenue and Forecast to 2027 (US$ Mn)

7.4       Analyzers

7.4.1        Overview

7.4.2        Analyzers Market Revenue and Forecast to 2027 (US$ Mn)

7.5       Consumables

7.5.1        Overview

7.5.2        Consumables Market Revenue and Forecast to 2027 (US$ Mn)

8.             Global Drug Abuse Testing Market Analysis– by Sample Type

8.1       Overview

8.2       Global Drug Abuse Testing Market Share by Sample Type 2018 & 2027 (%)

8.3       Blood

8.3.1        Overview

8.3.2        Blood Market Revenue and Forecast to 2027 (US$ Mn)

8.4       Urine

8.4.1        Overview

8.4.2        Urine Market Revenue and Forecast to 2027 (US$ Mn)

8.5       Saliva

8.5.1        Overview

8.5.2        Saliva Market Revenue and Forecast to 2027 (US$ Mn)

8.6       Other Sample Types

8.6.1        Overview

8.6.2        Other Sample Types Market Revenue and Forecast to 2027 (US$ Mn)

9.             Global Drug Abuse Testing Market Analysis– by End User

9.1       Overview

9.2       Global Drug Abuse Testing Market Share by End User 2018 & 2027 (%)

9.3       Hospitals

9.3.1        Overview

9.3.2        Hospitals Market Revenue and Forecast to 2027 (US$ Mn)

9.4       Diagnostic Laboratories

9.4.1        Overview

9.4.2        Diagnostic Laboratories Market Revenue and Forecast to 2027 (US$ Mn)

9.5       Forensic Laboratories

9.5.1        Overview

9.5.2        Forensic Laboratories Market Revenue and Forecast to 2027 (US$ Mn)

10.          Drug Abuse Testing Market Revenue and Forecasts to 2027 – Geographical Analysis

10.1    North America Drug Abuse Testing Market Revenue And Forecasts To 2027

10.1.1     North America Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.2     North America Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.1.3     North America Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)

10.1.4     North America Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.1.5     North America Drug Abuse Testing Market Revenue and Forecasts to 2027, By Country (%)

10.1.6     US Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.6.1    US Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.6.2    US Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.1.6.3    US Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)

10.1.6.4    US Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.1.7     Canada Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.7.1    Canada Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.7.2    Canada Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.1.7.3    Canada Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)

10.1.7.4    Canada Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.1.8     Mexico Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.8.1    Mexico Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.8.2    Mexico Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.1.8.3    Mexico Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)

10.1.8.4    Mexico Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.2    Europe Drug Abuse Testing Market Revenue And Forecasts To 2027

10.2.1     Europe Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.2.2     Europe Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.2.3     Europe Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)

10.2.4     Europe Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.2.5     Europe Drug Abuse Testing Market Revenue and Forecasts to 2027, By Country (%)

10.2.6     UK Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.2.6.1    UK Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.2.6.2    UK Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.2.6.3    UK Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)

10.2.6.4    UK Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.2.7     Germany Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.2.7.1    Germany Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.2.7.2    Germany Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.2.7.3    Germany Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)

10.2.7.4    Germany Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.2.8     France Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.2.8.1    France Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.2.8.2    France Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.2.8.3    France Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)

10.2.8.4    France Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.2.9     Italy Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.2.9.1    Italy Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.2.9.2    Italy Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.2.9.3    Italy Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)

10.2.9.4    Italy Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.2.10   Spain Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.2.10.1 Spain Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.2.10.2 Spain Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.2.10.3 Spain Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)

10.2.10.4 Spain Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.3    Asia Pacific Drug Abuse Testing Market Revenue and Forecasts to 2027

10.3.1     Asia Pacific Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.3.2     Asia Pacific Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.3.3     Asia Pacific Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)

10.3.4     Asia Pacific Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.3.5     Asia Pacific Drug Abuse Testing Market Revenue and Forecasts to 2027, By Country (%)

10.3.6     Japan Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.3.6.1    Japan Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.3.6.2    Japan Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.3.6.3    Japan Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)

10.3.6.4    Japan Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.3.7     China Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.3.7.1    China Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.3.7.2    China Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.3.7.3    China Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)

10.3.7.4    China Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.3.8     India Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.3.8.1    India Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.3.8.2    India Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.3.8.3    India Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)

10.3.8.4    India Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.3.9     South Korea Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.3.9.1    South Korea Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.3.9.2    South Korea Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.3.9.3    South Korea Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)

10.3.9.4    South Korea Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.3.10   Australia Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.3.10.1 Australia Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.3.10.2 Australia Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.3.10.3 Australia Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)

10.3.10.4 Australia Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.4    Middle East & Africa Drug Abuse Testing Market Revenue And Forecasts To 2027

10.4.1     Middle East & Africa Drug Abuse Testing Market Revenue And Forecasts To 2027 (US$ Mn)

10.4.2     Middle East & Africa Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.4.3     Middle East & Africa Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type  (US$ Mn)

10.4.4     Middle East & Africa Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.4.5     Middle East & Africa Drug Abuse Testing Market Revenue and Forecasts to 2027, By Country (%)

10.4.6     UAE Drug Abuse Testing Market Revenue And Forecasts To 2027 (US$ Mn)

10.4.6.1    UAE Drug Abuse Testing Market Revenue And Forecasts To 2027 (US$ Mn)

10.4.6.2    UAE Drug Abuse Testing Market Revenue And Forecasts To 2027, By Product (US$ Mn)

10.4.6.3    UAE Drug Abuse Testing Market Revenue And Forecasts To 2027, By Sample Type (US$ Mn)

10.4.6.4    UAE Drug Abuse Testing Market Revenue And Forecasts To 2027, By End User (US$ Mn)

10.4.7     Saudi Arabia Drug Abuse Testing Market Revenue And Forecasts To 2027 (US$ Mn)

10.4.7.1    Saudi Arabia Drug Abuse Testing Market Revenue And Forecasts To 2027 (US$ Mn)

10.4.7.2    Saudi Arabia Drug Abuse Testing Market Revenue And Forecasts To 2027, By Product (US$ Mn)

10.4.7.3    Saudi Arabia Drug Abuse Testing Market Revenue And Forecasts To 2027, By Sample Type (US$ Mn)

10.4.7.4    Saudi Arabia Drug Abuse Testing Market Revenue And Forecasts To 2027, By End User (US$ Mn)

10.4.8     South Africa Drug Abuse Testing Market Revenue And Forecasts To 2027 (US$ Mn)

10.4.8.1    South Africa Drug Abuse Testing Market Revenue And Forecasts To 2027 (US$ Mn)

10.4.8.2    South Africa Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.4.8.3    South Africa Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)

10.4.8.4    South Africa Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.5    South And Central America Drug Abuse Testing Market Revenue And Forecasts To 2027

10.5.1     South and Central America Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.5.2     South and Central America Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product  (US$ Mn)

10.5.3     South and Central America Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type  (US$ Mn)

10.5.4     South and Central America Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.5.5     South and Central America Drug Abuse Testing Market Revenue and Forecasts to 2027, By Country (%)

10.5.6     Argentina Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.5.6.1    Argentina Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.5.6.2    Argentina Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.5.6.3    Argentina Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)

10.5.6.4    Argentina Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.5.7     Brazil Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.5.7.1    Brazil Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.5.7.2    Brazil Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.5.7.3    Brazil Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)

10.5.7.4    Brazil Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

11.          Drug Abuse Testing Market– Industry Landscape

11.1    Overview

11.2    Comparative Company Analysis

11.3    Growth Strategies done by the companies in the Market, (%)

11.4    Organic Developments

11.4.1     Overview

11.5    Inorganic developments

11.5.1     Overview

12.          Drug Abuse Testing Market–Key company profiles

12.1    OraSure Technologies, Inc.

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Financial Overview

12.1.4     Product Portfolio

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.2    UCP Biosciences

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Financial Overview

12.2.4     Product Portfolio

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3    MEDACX Ltd.

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Financial Overview

12.3.4     Product Portfolio

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4    Beckman Coulter, Inc. (Danaher)

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Financial Overview

12.4.4     Product Portfolio

12.4.5     SWOT Analysis

12.4.6     Key Developments

12.5    Alcolizer Pty Ltd.

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Financial Overview

12.5.4     Product Portfolio

12.5.5     SWOT Analysis

12.5.6     Key Developments

12.6    Wondfo

12.6.1     Key Facts

12.6.2     Business Description

12.6.3     Financial Overview

12.6.4     Product Portfolio

12.6.5     SWOT Analysis

12.6.6     Key Developments

12.7    Redwood Toxicology LAboratory (Abbott)

12.7.1     Key Facts

12.7.2     Business Description

12.7.3     Financial Overview

12.7.4     Product Portfolio

12.7.5     SWOT Analysis

12.7.6     Key Developments

12.8    F. Hoffmann-La Roche Ltd.

12.8.1     Key Facts

12.8.2     Business Description

12.8.3     Financial Overview

12.8.4     Product Portfolio

12.8.5     SWOT Analysis

12.8.6     Key Developments

12.9    Siemens

12.9.1     Key Facts

12.9.2     Business Description

12.9.3     Financial Information

12.9.4     Product Portfolio

12.9.5     SWOT Analysis

12.9.6     Key Developments

12.10 Thermo Fisher Scientific, Inc.

12.10.1   Key Facts

12.10.2   Business Description

12.10.3   Financial Information

12.10.4   Product Portfolio

12.10.5   SWOT Analysis

12.10.6   Key Developments

12.11 Drägerwerk AG & Co. KGaA

12.11.1   Key Facts

12.11.2   Business Description

12.11.3   Financial Overview

12.11.4   Product Portfolio

12.11.5   SWOT Analysis

12.11.6   Key Developments

12.12 American Screening Corporation, Inc

12.12.1   Key Facts

12.12.2   Business Description

12.12.3   Financial Overview

12.12.4   1.5.4 Product Portfolio

12.12.5   SWOT Analysis

12.12.6   Key Developments

12.13 Mercedes Medical

12.13.1   Key Facts

12.13.2   Business Description

12.13.3   Financial Overview

12.13.4   Product Portfolio

12.13.5   SWOT Analysis

12.13.6   Key Developments

12.14 Alfa Scientific Designs, Inc.

12.14.1   Key Facts

12.14.2   Business Description

12.14.3   Financial Overview

12.14.4   Product Portfolio

12.14.5   SWOT Analysis

12.14.6   Key Developments

12.15 Express Diagnostics Int'l, Inc.

12.15.1   Key Facts

12.15.2   Business Description

12.15.3   Financial Overview

12.15.4   Product Portfolio

12.15.5   SWOT Analysis

12.15.6   Key Developments

12.16 Omega Laboratories, Inc.

12.16.1   Key Facts

12.16.2   Business Description

12.16.3   Financial Overview

12.16.4   Product Portfolio

12.16.5   SWOT Analysis

12.16.6   Key Developments

12.17 Laboratorio Sodré

12.17.1   Key Facts

12.17.2   Business Description

12.17.3   Financial Overview

12.17.4   Product Portfolio

12.17.5   SWOT Analysis

12.17.6   Key Developments

13.          Appendix

13.1    About The Insight Partners

13.2    Glossary of Terms

LIST OF TABLES

Table 1.            North America Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 2.            North America Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type  (US$ Mn)

Table 3.            North America Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 4.            US Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 5.            US Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)

Table 6.            US Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 7.            Canada Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 8.            Canada Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)

Table 9.            Canada Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 10.         Mexico Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 11.         Mexico Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)

Table 12.         Mexico Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 13.         Europe Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 14.         Europe Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)

Table 15.         Europe Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 16.         UK Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 17.         UK Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)

Table 18.         UK Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 19.         Germany Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 20.         Germany Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)

Table 21.         Germany Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 22.         France Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 23.         France Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)

Table 24.         France Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 25.         Italy Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 26.         Italy Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)

Table 27.         Italy Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 28.         Spain Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 29.         Spain Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)

Table 30.         Spain Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 31.         Asia Pacific Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 32.         Asia Pacific Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)

Table 33.         Asia Pacific Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 34.         Japan Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 35.         Japan Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)

Table 36.         Japan Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 37.         China Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 38.         China Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)

Table 39.         China Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 40.         India Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 41.         India Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)

Table 42.         India Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 43.         South Korea Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 44.         South Korea Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)

Table 45.         South Korea Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 46.         Australia Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 47.         Australia Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)

Table 48.         Australia Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 49.         Middle East & Africa Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 50.         Middle East & Africa Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)

Table 51.         Middle East & Africa Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 52.         UAE Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 53.         UAE Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)

Table 54.         UAE Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 55.         Saudi Arabia Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 56.         Saudi Arabia Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)

Table 57.         Saudi Arabia Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 58.         South Africa Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 59.         South Africa Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)

Table 60.         South Africa Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 61.         South and Central America Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 62.         South and Central America Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type  (US$ Mn)

Table 63.         South and Central America Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 64.         Argentina Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 65.         Argentina Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)

Table 66.         Argentina Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 67.         Brazil Drug Abuse Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 68.         Brazil Drug Abuse Testing Market Revenue And Forecasts to 2027, By Sample Type (US$ Mn)

Table 69.         Brazil Drug Abuse Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 70.         Organic Developments Done By Companies

Table 71.         Inorganic developments done by Companies

Table 72.         Glossary of Terms, Drug Abuse Testing Market

 

LIST OF FIGURES

Figure 1.          Drug Abuse Testing Market Segmentation

Figure 2.          Drug Abuse Testing Segmentation, By Region

Figure 3.          Asia Pacific Drug Abuse Testing Market, Revenue (Us$ Mn), 2018 & 2027

Figure 4.          Global Drug Abuse Testing Market By Product, Market Share (%), 2018

Figure 5.          Global Drug Abuse Testing Market By Sample Type, Market Share (%), 2018

Figure 6.          Global Drug Abuse Testing Market By End User, Market Share (%), 2018

Figure 7.          North America : PEST Analysis

Figure 8.          Europe: PEST Analysis

Figure 9.          Asia - Pacific: PEST Analysis

Figure 10.       Middle East & Africa: PEST Analysis

Figure 11.       South & Central America: PEST Analysis

Figure 12.       Drug Abuse Testing Market Impact Analysis of Driver and Restraints

Figure 13.       Global Drug Abuse Testing Market – Revenue Forecasts And Analysis – 2018- 2027

Figure 14.       Global Drug Abuse Testing Market – By Geography Forecasts And Analysis – 2018- 2027

Figure 15.       Prominent Players In The Drug Abuse Testing Market

Figure 16.       Global Drug Abuse Testing Market Share by Product 2018 & 2027 (%)

Figure 17.       Rapid Testing Devices Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 18.       Analyzers Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 19.       Consumables Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 20.       Global Drug Abuse Testing Market Share by Sample Type 2018 & 2027 (%)

Figure 21.       Blood Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 22.       Urine Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 23.       Saliva Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 24.       Other Sample Types Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 25.       Global Drug Abuse Testing Market Share by End User 2018 & 2027 (%)

Figure 26.       Hospitals Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 27.       Diagnostic Laboratories Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 28.       Forensic Laboratories Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 29.       North America Drug Abuse Testing Market Revenue Overview, by Country, 2018 (US$ Mn)

Figure 30.       North America Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 31.       North America Drug Abuse Testing Market Revenue and Forecasts to 2027, By Country (%)

Figure 32.       US Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 33.       Canada Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 34.       Mexico Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 35.       Europe Drug Abuse Testing Market Revenue Overview, by Country, 2018 (US$ Mn)

Figure 36.       Europe Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 37.       Europe Drug Abuse Testing Market Revenue and Forecasts to 2027, By Country (%)

Figure 38.       UK Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 39.       Germany Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 40.       France Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 41.       Italy Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 42.       Spain Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 43.       Asia Pacific Drug Abuse Testing Market Revenue Overview, by Country, 2018 (US$ Mn)

Figure 44.       Asia Pacific Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 45.       Asia Pacific Drug Abuse Testing Market Revenue and Forecasts to 2027, By Country (%)

Figure 46.       Japan Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 47.       China Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 48.       India Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 49.       South Korea Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 50.       Australia Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 51.       Middle East & Africa Drug Abuse Testing Market Revenue Overview, by Country, 2018 (US$ Mn)

Figure 52.       Middle East & Africa Drug Abuse Testing Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 53.       Middle East & Africa Drug Abuse Testing Market Revenue and Forecasts to 2027, By Country (%)

Figure 54.       UAE Drug Abuse Testing Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 55.       Saudi Arabia Drug Abuse Testing Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 56.       South Africa Drug Abuse Testing Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 57.       South and Central America Drug Abuse Testing Market Revenue Overview, by Country, 2018 (US$ Mn)

Figure 58.       South and Central America Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 59.       South and Central America Drug Abuse Testing Market Revenue and Forecasts to 2027, By Country (%)

Figure 60.       Argentina Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 61.       Brazil Drug Abuse Testing Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 62.       Comparative Company Analysis

Figure 63.       Growth Strategies done by the companies in the Market, (%)

 

The List of Companies

  1. Redwood Toxicology Laboratory (Abbott)
  2. F. Hoffmann-La Roche Ltd.
  3. Thermo Fisher Scientific, Inc.
  4. OraSure Technologies, Inc.
  5. UCP Biosciences
  6. MEDACX Ltd.
  7. Beckman Coulter, Inc. (Danaher)
  8. Alcolizer Pty Ltd.
  9. Wondfo
  10. DRÄGERWERK AG & CO. KGAA
  11. American Screening Corporation, Inc
  12. Mercedes Medical, Alfa Scientific Designs, Inc.
  13. Express Diagnostics Int'l, Inc.
  14. Omega Laboratories, Inc.
  15. Laboratorio Sodré.
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the drug abuse testing market.

 

  • Highlights key business priorities in order to assist companies to realign their business strategies.

 

  • The key findings and recommendations highlight crucial progressive industry trends in the global drug abuse testing market, thereby allowing players across the value chain to develop effective long-term strategies.

 

  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

 

  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

 

  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.